← Back to headlines
Arbutus Biopharma Listed Among Top Biotech Penny Stocks for 2026
Arbutus Biopharma has been identified as one of the top 10 biotech penny stocks to consider buying in 2026. This listing is part of a market recommendation.
1 May, 09:22 — 1 May, 09:22
Sources
Showing 1 of 1 sources
Related Stories
Treasury Secretary Bessent's Bond Strategy Faces Scrutiny and Criticism
8h ago
Analysts Assess NVIDIA's Valuation and Volatility Risks Following Weekly Stock Decline
10h ago
Richtech Robotics Announces Stock Repurchase Program, Shares Rise
12h ago
Apollo, KKR, and IFM Investors Finalists in AB Ports Stake Sale
12h ago